Login / Signup

The effect of risankizumab on achieving minimal clinically important differences in patient-reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2.

L E KristensenA M SolimanKim A PappL BarcombA EldredA Östör
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
These data demonstrate that patients with PsA receiving RZB treatment are more likely to report clinically important improvements in PROs compared with patients receiving PBO.
Keyphrases
  • patient reported outcomes
  • prostate cancer
  • electronic health record
  • big data
  • radical prostatectomy
  • combination therapy
  • smoking cessation
  • artificial intelligence